Minimally Invasive Surgical Instrument Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

Minimally Invasive Surgical Instrument Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

Minimally invasive surgical instruments are thriving in surgical instrument market for decades, owing to advance technology, substantial benefits over conventional techniques for a number of surgical interventions. This rapid growth has been possible due to significant developments in medical technology, which partly solved some of the technical and clinical challenges associated with minimally invasive surgical techniques. Minimally Invasive Surgery (MIS) is performed without making a major incision, patients experience less trauma, shorter hospital stays, and quick recovery time. Conditions such as lungs tumors, cancer, emphysema, repair of heart valve, atrial fibrillation (AFib), gall bladder stones, kidney stones, kidney cysts, endometriosis, ovarian cysts, liver cancer, colon or rectal cancer, pancreatic cancer, gastro esophageal reflux disease (GERD) and etc., can be treated with minimally invasive surgeries.

Market Dynamics

Minimally invasive surgical instrument market size is expected to witness significant growth owing to increasing number of diseases, which can be treated with minimally invasive surgeries such as cancer and heart diseases. Minimally invasive surgical instruments are widely used for removal of cancerous tumors from brain, stomach, kidney, ovary, prostate, pancreas, etc. According to the National Cancer Institute (NCI) in 2016, there were an estimated 16.8 million people suffering cancer in the U.S., and around 595,690 deaths occurred from the disease. Moreover, the number of people suffering from cancer is expected to reach to 19 million by 2024.

However, the risks and complications associated with minimally invasive instruments such as punctures, perforations, surgical site infection, and anaesthesia problems hinder the minimally invasive surgical instrument market growth. According to International Journal of Clinical Anaesthesiology 2014 studies, Intestinal perforation and bleeding is most common complication of minimally invasive surgery. Overall prevalence of complications in laparoscopy is less ranges from 0.3% to 0.5%.

Key features of the study:

• This report provides in-depth analysis of the minimally invasive surgical instrument market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players.
• It profiles key players in the global minimally invasive surgical instrument market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include Medtronic Plc., Ethicon Inc., Aesculapius Inc., Stryker Corporation, B. Braun Melsungen Ag and Smith & Nephew Plc. Other players in this market are ConMed Corporation, Abbott Laboratories, Applied Biomedical Resources Corporation, Boston Scientific Corporation, Microline Surgical, Alcon Laboratories Inc., and Zimmer Biomet Holdings Inc.
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global minimally invasive surgical instrument market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for minimally invasive surgical instrument market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

• Global Minimally Invasive Surgical Instrument Market, By Product Type:
• Handheld Instruments
• Electrosurgical Instruments
• Guiding Devices
• Inflation Systems
• Monitoring and Visualization Devices
• Global Minimally Invasive Surgical Instrument Market, By Application:
• Cosmetic Surgery
• Urology
• Gynecology
• Ophthalmology
• Gastrointestinal Surgery
• Cardiovascular Surgery
• Respiratory Surgery
• Others
• Global Minimally Invasive Surgical Instrument Market, By End User:
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Global Minimally Invasive Surgical Instrument Market, By Region:
• North America
• By Country:
• U.S.
• Canada
• By Product Type:
• Handheld Instruments
• Electrosurgical Instruments
• Guiding Devices
• Inflation Systems
• Monitoring and Visualization Devices
• By Application:
• Cosmetic Surgery
• Urology
• Gynecology
• Ophthalmology
• Gastrointestinal Surgery
• Cardiovascular Surgery
• Respiratory Surgery
• Others
• By End User:
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Europe
• By Country:
• U.K.
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe
• By Product Type:
• Handheld Instruments
• Electrosurgical Instruments
• Guiding Devices
• Inflation Systems
• Monitoring and Visualization Devices
• By Application:
• Cosmetic Surgery
• Urology
• Gynecology
• Ophthalmology
• Gastrointestinal Surgery
• Cardiovascular Surgery
• Respiratory Surgery
• Others
• By End User:
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Asia Pacific
• By Country:
• Australia
• India
• China
• Japan
• ASEAN
• South Korea
• Rest of Asia Pacific
• By Product Type:
• Handheld Instruments
• Electrosurgical Instruments
• Guiding Devices
• Inflation Systems
• Monitoring and Visualization Devices
• By Application:
• Cosmetic Surgery
• Urology
• Gynecology
• Ophthalmology
• Gastrointestinal Surgery
• Cardiovascular Surgery
• Respiratory Surgery
• Others
• By End User:
• Hospitals
• Clinics
• Ambulatory Surgical Clinics
• Middle East
• By Country:
• GCC
• Israel
• Rest of Middle East
• By Product Type
• Handheld Instruments
• Electrosurgical Instruments
• Guiding Devices
• Inflation Systems
• Monitoring and Visualization Devices
• By Application:
• Cosmetic Surgery
• Urology
• Gynecology
• Ophthalmology
• Gastrointestinal Surgery
• Cardiovascular Surgery
• Respiratory Surgery
• Others
• By End User:
• Hospitals
• Clinics
• Ambulatory Surgical Clinics
• Africa
• By Country:
• South Africa
• Central Africa
• North Africa
• By Product Type:
• Handheld Instruments
• Electrosurgical Instruments
• Guiding Devices
• Inflation Systems
• Monitoring and Visualization Devices
• By Application:
• Cosmetic Surgery
• Urology
• Gynecology
• Ophthalmology
• Gastrointestinal Surgery
• Cardiovascular Surgery
• Respiratory Surgery
• Others
• By End User:
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Company Profiles
• Medtronic Plc.
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Highlights
• Strategies
• Ethicon Inc.
• Aesculap Inc.
• Stryker Corporation
• B. Braun Melsungen Ag
• Smith & Nephew Plc.
• ConMed Corporation
• Abbott Laboratories
• Applied Biomedical Resources Corporation
• Boston Scientific Corporation
• Microline Surgical
• Alcon Laboratories Inc.
• Zimmer Biomet Holdings Inc.

“*” marked represents similar segmentation in other categories in the respective section.